BNP Paribas Exane Upgrades Adient (ADNT) to Outperform
BNP Paribas Exane analyst James Picariello upgraded Adient (NYSE: ADNT) from Neutral to Outperform with a price target of $26.00.
For an analyst ratings summary and ratings history on Adient click here. For more ratings news on Adient click here.
Shares of Adient closed at $21.58 yesterday.
